HERZKLAPPENDICHTUNGSVORRICHTUNGEN

European patent · EP3689299 · In force

Register entry

Publication number
EP3689299
Application number
EP20161693
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 18, 2018
Published
Aug 5, 2020
Granted
Feb 9, 2022
Protection ends at the latest
Apr 17, 2038
Next annual fee due
Apr 30, 2027
IPC classes
A61F 2/24 (2006.01)
A61B 17/12 (2006.01)
A61B 17/00 (2006.01)
A61B 17/064 (2006.01)
Priority
US 201762486835 P 18.04.2017
US 201815884193 30.01.2018
US 201815909803 01.03.2018
US 201815910951 02.03.2018
US 201815914143 07.03.2018
US 201815927814 21.03.2018
US 201815946604 05.04.2018
US 201815953220 13.04.2018
US 201815953263 13.04.2018
US 201815953283 13.04.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Dec 21, 2022

    Change

    Published in Swissreg on 21.12.2022

  6. Feb 9, 2022

    Granted

    Published in Swissreg on 09.02.2022

Parties

Holder

Edwards Lifesciences Corporation

One Edwards Way, Irvine, CA 92614, US

Inventor

DOMINICK, Douglas Thomas

Irvine, CA 92614, US

MORATORIO, Guillermo W.

Irvine, CA 92614, US

CHEN, Jensen

Irvine, CA 92614, US

FRESCHAUF, Lauren R.

Irvine, CA 92614, US

DIXON, Eric Robert

Irvine, CA 92614, US

CAO, Hengchu

Irvine, CA 92614, US

DELGADO, Sergio

Irvine, CA 92614, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.